Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-136073
Filing Date
2013-04-01
Accepted
2013-04-01 13:22:34
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d444203d10k.htm 10-K 921579
2 EX-21 d444203dex21.htm EX-21 3680
3 EX-23.1 d444203dex231.htm EX-23.1 1838
4 EX-31.1 d444203dex311.htm EX-31.1 10065
5 EX-31.2 d444203dex312.htm EX-31.2 10463
6 EX-32.1 d444203dex321.htm EX-32.1 4231
7 EX-32.2 d444203dex322.htm EX-32.2 4685
  Complete submission text file 0001193125-13-136073.txt   5636344

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alse-20121231.xml EX-101.INS 625599
9 XBRL TAXONOMY EXTENSION SCHEMA alse-20121231.xsd EX-101.SCH 61273
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alse-20121231_cal.xml EX-101.CAL 67599
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alse-20121231_def.xml EX-101.DEF 209289
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE alse-20121231_lab.xml EX-101.LAB 445937
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alse-20121231_pre.xml EX-101.PRE 328521
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

EIN.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-06533 | Film No.: 13730093
SIC: 2834 Pharmaceutical Preparations